APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Radioactive Microsphere Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Radioactive Microsphere Injection Market Outlook and Growth Opportunities 2026

23 December 2025196 pages

Choose your research edition.

Industry ResearchMedical Radioactive Microsphere Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Radioactive Microsphere Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Medical Radioactive Microsphere Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Radioactive Microsphere Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Radioactive Microsphere Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Medical Radioactive Microsphere Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Radioactive Microsphere Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Radioactive Microsphere Injection market include YH Nu-Med, Grand Pharmaceutical Group Limited, New Radiomedicine Technology, Boston Scientific, Terumo, Sirtex Medical Limited, BWXT Medical, AtomVie and ABK Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Radioactive Microsphere Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Radioactive Microsphere Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Radioactive Microsphere Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Radioactive Microsphere Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Radioactive Microsphere Injection Segment by Company

YH Nu-Med

Grand Pharmaceutical Group Limited

New Radiomedicine Technology

Boston Scientific

Terumo

Sirtex Medical Limited

BWXT Medical

AtomVie

ABK Biomedical

Medical Radioactive Microsphere Injection Segment by Type

Holmium 166 Microsphere Injection

Yttrium 90 Microsphere Injection

Others

Medical Radioactive Microsphere Injection Segment by Application

Cancer Treatment

Diagnosis

Others

Medical Radioactive Microsphere Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Radioactive Microsphere Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Radioactive Microsphere Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Radioactive Microsphere Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Radioactive Microsphere Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioactive Microsphere Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Radioactive Microsphere Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioactive Microsphere Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Radioactive Microsphere Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Radioactive Microsphere Injection industry.

Chapter 3: Detailed analysis of Medical Radioactive Microsphere Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Radioactive Microsphere Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Radioactive Microsphere Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Radioactive Microsphere Injection Industry Trends Table 2. Medical Radioactive Microsphere Injection Industry Drivers Table 3. Medical Radioactive Microsphere Injection Industry Opportunities and Challenges Table 4. Medical Radioactive Microsphere Injection Industry Restraints Table 5. Global Medical Radioactive Microsphere Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Radioactive Microsphere Injection Revenue Share by Company (2021-2026) Table 7. Global Medical Radioactive Microsphere Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Medical Radioactive Microsphere Injection Sales Volume Share by Company (2021-2026) Table 9. Global Medical Radioactive Microsphere Injection Average Price (USD/unit) of Company (2021-2026) Table 10. Global Medical Radioactive Microsphere Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Radioactive Microsphere Injection Key Company Manufacturing Base & Headquarters Table 12. Global Medical Radioactive Microsphere Injection Company, Product Type & Application Table 13. Global Medical Radioactive Microsphere Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Radioactive Microsphere Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Holmium 166 Microsphere Injection Table 18. Significant Companies of Yttrium 90 Microsphere Injection Table 19. Significant Companies of Others Table 20. Global Medical Radioactive Microsphere Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Medical Radioactive Microsphere Injection Sales Volume by Type (2021-2026) & (k units) Table 22. Global Medical Radioactive Microsphere Injection Sales Volume by Type (2027-2032) & (k units) Table 23. Global Medical Radioactive Microsphere Injection Sales Volume Share by Type (2021-2026) Table 24. Global Medical Radioactive Microsphere Injection Sales Volume Share by Type (2027-2032) Table 25. Global Medical Radioactive Microsphere Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Radioactive Microsphere Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Medical Radioactive Microsphere Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Medical Radioactive Microsphere Injection Sales Value Share by Type (2021-2026) Table 29. Global Medical Radioactive Microsphere Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cancer Treatment Table 31. Significant Companies of Diagnosis Table 32. Significant Companies of Others Table 33. Global Medical Radioactive Microsphere Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Medical Radioactive Microsphere Injection Sales Volume by Application (2021-2026) & (k units) Table 35. Global Medical Radioactive Microsphere Injection Sales Volume by Application (2027-2032) & (k units) Table 36. Global Medical Radioactive Microsphere Injection Sales Volume Share by Application (2021-2026) Table 37. Global Medical Radioactive Microsphere Injection Sales Volume Share by Application (2027-2032) Table 38. Global Medical Radioactive Microsphere Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Medical Radioactive Microsphere Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Medical Radioactive Microsphere Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Medical Radioactive Microsphere Injection Sales Value Share by Application (2021-2026) Table 42. Global Medical Radioactive Microsphere Injection Sales Value Share by Application (2027-2032) Table 43. Global Medical Radioactive Microsphere Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Medical Radioactive Microsphere Injection Sales by Region (2021-2026) & (k units) Table 45. Global Medical Radioactive Microsphere Injection Sales Market Share by Region (2021-2026) Table 46. Global Medical Radioactive Microsphere Injection Sales by Region (2027-2032) & (k units) Table 47. Global Medical Radioactive Microsphere Injection Sales Market Share by Region (2027-2032) Table 48. Global Medical Radioactive Microsphere Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Medical Radioactive Microsphere Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Medical Radioactive Microsphere Injection Sales Value Share by Region (2021-2026) Table 51. Global Medical Radioactive Microsphere Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Medical Radioactive Microsphere Injection Sales Value Share by Region (2027-2032) Table 53. Global Medical Radioactive Microsphere Injection Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Medical Radioactive Microsphere Injection Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Medical Radioactive Microsphere Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Medical Radioactive Microsphere Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Medical Radioactive Microsphere Injection Sales by Country (2021-2026) & (k units) Table 58. Global Medical Radioactive Microsphere Injection Sales Market Share by Country (2021-2026) Table 59. Global Medical Radioactive Microsphere Injection Sales by Country (2027-2032) & (k units) Table 60. Global Medical Radioactive Microsphere Injection Sales Market Share by Country (2027-2032) Table 61. Global Medical Radioactive Microsphere Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Medical Radioactive Microsphere Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Medical Radioactive Microsphere Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Medical Radioactive Microsphere Injection Sales Value Market Share by Country (2027-2032) Table 65. YH Nu-Med Company Information Table 66. YH Nu-Med Business Overview Table 67. YH Nu-Med Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. YH Nu-Med Medical Radioactive Microsphere Injection Product Portfolio Table 69. YH Nu-Med Recent Development Table 70. Grand Pharmaceutical Group Limited Company Information Table 71. Grand Pharmaceutical Group Limited Business Overview Table 72. Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Product Portfolio Table 74. Grand Pharmaceutical Group Limited Recent Development Table 75. New Radiomedicine Technology Company Information Table 76. New Radiomedicine Technology Business Overview Table 77. New Radiomedicine Technology Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. New Radiomedicine Technology Medical Radioactive Microsphere Injection Product Portfolio Table 79. New Radiomedicine Technology Recent Development Table 80. Boston Scientific Company Information Table 81. Boston Scientific Business Overview Table 82. Boston Scientific Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Boston Scientific Medical Radioactive Microsphere Injection Product Portfolio Table 84. Boston Scientific Recent Development Table 85. Terumo Company Information Table 86. Terumo Business Overview Table 87. Terumo Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Terumo Medical Radioactive Microsphere Injection Product Portfolio Table 89. Terumo Recent Development Table 90. Sirtex Medical Limited Company Information Table 91. Sirtex Medical Limited Business Overview Table 92. Sirtex Medical Limited Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Sirtex Medical Limited Medical Radioactive Microsphere Injection Product Portfolio Table 94. Sirtex Medical Limited Recent Development Table 95. BWXT Medical Company Information Table 96. BWXT Medical Business Overview Table 97. BWXT Medical Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. BWXT Medical Medical Radioactive Microsphere Injection Product Portfolio Table 99. BWXT Medical Recent Development Table 100. AtomVie Company Information Table 101. AtomVie Business Overview Table 102. AtomVie Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. AtomVie Medical Radioactive Microsphere Injection Product Portfolio Table 104. AtomVie Recent Development Table 105. ABK Biomedical Company Information Table 106. ABK Biomedical Business Overview Table 107. ABK Biomedical Medical Radioactive Microsphere Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. ABK Biomedical Medical Radioactive Microsphere Injection Product Portfolio Table 109. ABK Biomedical Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Medical Radioactive Microsphere Injection Distributors List Table 113. Medical Radioactive Microsphere Injection Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Medical Radioactive Microsphere Injection Product Image Figure 2. Global Medical Radioactive Microsphere Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Radioactive Microsphere Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Radioactive Microsphere Injection Sales (2021-2032) & (k units) Figure 5. Global Medical Radioactive Microsphere Injection Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Medical Radioactive Microsphere Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Holmium 166 Microsphere Injection Image Figure 10. Yttrium 90 Microsphere Injection Image Figure 11. Others Image Figure 12. Global Medical Radioactive Microsphere Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Medical Radioactive Microsphere Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Radioactive Microsphere Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Medical Radioactive Microsphere Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medical Radioactive Microsphere Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Radioactive Microsphere Injection Sales Value Share by Type (2021-2032) Figure 18. Cancer Treatment Image Figure 19. Diagnosis Image Figure 20. Others Image Figure 21. Global Medical Radioactive Microsphere Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Medical Radioactive Microsphere Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Medical Radioactive Microsphere Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Medical Radioactive Microsphere Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Medical Radioactive Microsphere Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Medical Radioactive Microsphere Injection Sales Value Share by Application (2021-2032) Figure 27. Global Medical Radioactive Microsphere Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Medical Radioactive Microsphere Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Medical Radioactive Microsphere Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Medical Radioactive Microsphere Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Medical Radioactive Microsphere Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Medical Radioactive Microsphere Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Medical Radioactive Microsphere Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Medical Radioactive Microsphere Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Medical Radioactive Microsphere Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Medical Radioactive Microsphere Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Medical Radioactive Microsphere Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Medical Radioactive Microsphere Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Medical Radioactive Microsphere Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Medical Radioactive Microsphere Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Medical Radioactive Microsphere Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Medical Radioactive Microsphere Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Holmium 166 Microsphere Injection
  • Yttrium 90 Microsphere Injection
  • Others
Applications
  • Cancer Treatment
  • Diagnosis
  • Others
Companies covered
  • YH Nu-Med
  • Grand Pharmaceutical Group Limited
  • New Radiomedicine Technology
  • Boston Scientific
  • Terumo
  • Sirtex Medical Limited
  • BWXT Medical
  • AtomVie
  • ABK Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Radioactive Microsphere Injection Sales Value (2021-2032)
  4. 1.2.2 Global Medical Radioactive Microsphere Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Radioactive Microsphere Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Radioactive Microsphere Injection Market Dynamics
  1. 2.1 Medical Radioactive Microsphere Injection Industry Trends
  2. 2.2 Medical Radioactive Microsphere Injection Industry Drivers
  3. 2.3 Medical Radioactive Microsphere Injection Industry Opportunities and Challenges
  4. 2.4 Medical Radioactive Microsphere Injection Industry Restraints
3 Medical Radioactive Microsphere Injection Market by Company
  1. 3.1 Global Medical Radioactive Microsphere Injection Company Revenue Ranking in 2025
  2. 3.2 Global Medical Radioactive Microsphere Injection Revenue by Company (2021-2026)
  3. 3.3 Global Medical Radioactive Microsphere Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Radioactive Microsphere Injection Average Price by Company (2021-2026)
  5. 3.5 Global Medical Radioactive Microsphere Injection Company Ranking (2024-2026)
  6. 3.6 Global Medical Radioactive Microsphere Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Radioactive Microsphere Injection Company Product Type and Application
  8. 3.8 Global Medical Radioactive Microsphere Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Radioactive Microsphere Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Radioactive Microsphere Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Radioactive Microsphere Injection Market by Type
  1. 4.1 Medical Radioactive Microsphere Injection Type Introduction
  2. 4.1.1 Holmium 166 Microsphere Injection
  3. 4.1.2 Yttrium 90 Microsphere Injection
  4. 4.1.3 Others
  5. 4.2 Global Medical Radioactive Microsphere Injection Sales Volume by Type
  6. 4.2.1 Global Medical Radioactive Microsphere Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Radioactive Microsphere Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Medical Radioactive Microsphere Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Medical Radioactive Microsphere Injection Sales Value by Type
  10. 4.3.1 Global Medical Radioactive Microsphere Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Medical Radioactive Microsphere Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Medical Radioactive Microsphere Injection Sales Value Share by Type (2021-2032)
5 Medical Radioactive Microsphere Injection Market by Application
  1. 5.1 Medical Radioactive Microsphere Injection Application Introduction
  2. 5.1.1 Cancer Treatment
  3. 5.1.2 Diagnosis
  4. 5.1.3 Others
  5. 5.2 Global Medical Radioactive Microsphere Injection Sales Volume by Application
  6. 5.2.1 Global Medical Radioactive Microsphere Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Radioactive Microsphere Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Medical Radioactive Microsphere Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Medical Radioactive Microsphere Injection Sales Value by Application
  10. 5.3.1 Global Medical Radioactive Microsphere Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Medical Radioactive Microsphere Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Medical Radioactive Microsphere Injection Sales Value Share by Application (2021-2032)
6 Medical Radioactive Microsphere Injection Regional Sales and Value Analysis
  1. 6.1 Global Medical Radioactive Microsphere Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Radioactive Microsphere Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Radioactive Microsphere Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Radioactive Microsphere Injection Sales by Region (2027-2032)
  5. 6.3 Global Medical Radioactive Microsphere Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Radioactive Microsphere Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Radioactive Microsphere Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Radioactive Microsphere Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Radioactive Microsphere Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Radioactive Microsphere Injection Sales Value (2021-2032)
  12. 6.6.2 North America Medical Radioactive Microsphere Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Radioactive Microsphere Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Radioactive Microsphere Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Radioactive Microsphere Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Radioactive Microsphere Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Radioactive Microsphere Injection Sales Value (2021-2032)
  21. 6.9.2 South America Medical Radioactive Microsphere Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Radioactive Microsphere Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Radioactive Microsphere Injection Sales Value Share by Country, 2025 VS 2032
7 Medical Radioactive Microsphere Injection Country-level Sales and Value Analysis
  1. 7.1 Global Medical Radioactive Microsphere Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Radioactive Microsphere Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Radioactive Microsphere Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Radioactive Microsphere Injection Sales by Country (2027-2032)
  6. 7.4 Global Medical Radioactive Microsphere Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Radioactive Microsphere Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Radioactive Microsphere Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Radioactive Microsphere Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Radioactive Microsphere Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Radioactive Microsphere Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 YH Nu-Med
  2. 8.1.1 YH Nu-Med Company Information
  3. 8.1.2 YH Nu-Med Business Overview
  4. 8.1.3 YH Nu-Med Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 YH Nu-Med Medical Radioactive Microsphere Injection Product Portfolio
  6. 8.1.5 YH Nu-Med Recent Developments
  7. 8.2 Grand Pharmaceutical Group Limited
  8. 8.2.1 Grand Pharmaceutical Group Limited Company Information
  9. 8.2.2 Grand Pharmaceutical Group Limited Business Overview
  10. 8.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Product Portfolio
  12. 8.2.5 Grand Pharmaceutical Group Limited Recent Developments
  13. 8.3 New Radiomedicine Technology
  14. 8.3.1 New Radiomedicine Technology Company Information
  15. 8.3.2 New Radiomedicine Technology Business Overview
  16. 8.3.3 New Radiomedicine Technology Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 New Radiomedicine Technology Medical Radioactive Microsphere Injection Product Portfolio
  18. 8.3.5 New Radiomedicine Technology Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Medical Radioactive Microsphere Injection Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 Terumo
  26. 8.5.1 Terumo Company Information
  27. 8.5.2 Terumo Business Overview
  28. 8.5.3 Terumo Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Terumo Medical Radioactive Microsphere Injection Product Portfolio
  30. 8.5.5 Terumo Recent Developments
  31. 8.6 Sirtex Medical Limited
  32. 8.6.1 Sirtex Medical Limited Company Information
  33. 8.6.2 Sirtex Medical Limited Business Overview
  34. 8.6.3 Sirtex Medical Limited Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sirtex Medical Limited Medical Radioactive Microsphere Injection Product Portfolio
  36. 8.6.5 Sirtex Medical Limited Recent Developments
  37. 8.7 BWXT Medical
  38. 8.7.1 BWXT Medical Company Information
  39. 8.7.2 BWXT Medical Business Overview
  40. 8.7.3 BWXT Medical Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BWXT Medical Medical Radioactive Microsphere Injection Product Portfolio
  42. 8.7.5 BWXT Medical Recent Developments
  43. 8.8 AtomVie
  44. 8.8.1 AtomVie Company Information
  45. 8.8.2 AtomVie Business Overview
  46. 8.8.3 AtomVie Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AtomVie Medical Radioactive Microsphere Injection Product Portfolio
  48. 8.8.5 AtomVie Recent Developments
  49. 8.9 ABK Biomedical
  50. 8.9.1 ABK Biomedical Company Information
  51. 8.9.2 ABK Biomedical Business Overview
  52. 8.9.3 ABK Biomedical Medical Radioactive Microsphere Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ABK Biomedical Medical Radioactive Microsphere Injection Product Portfolio
  54. 8.9.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Radioactive Microsphere Injection Value Chain Analysis
  2. 9.1.1 Medical Radioactive Microsphere Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Radioactive Microsphere Injection Sales Mode & Process
  6. 9.2 Medical Radioactive Microsphere Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Radioactive Microsphere Injection Distributors
  9. 9.2.3 Medical Radioactive Microsphere Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst